Home  /  HEOR  /  Systematic Literature Review
HEOR · PRISMA 2020

Systematic Literature Review and Meta-Analysis

Almost every HEOR deliverable rests on a solid evidence base, and a systematic literature review is how that base is built rigorously rather than selectively. EvySaif conducts systematic literature reviews and meta-analyses to the PRISMA 2020 standard, producing the transparent, reproducible evidence synthesis that underpins economic models, value dossiers, and HTA submissions.

PRISMA 2020Dual screeningMeta-analysisNMA & ITC
Evidence · Build
ProtocolPredefined criteria, registered
SearchDocumented strategy
ScreenDual independent screening
SynthesizeMeta-analysis or NMA
The Pathway

Reproducible by design

A systematic literature review is defined by its method: a documented search strategy, predefined eligibility criteria, dual independent screening, structured data extraction, and a transparent record of what was found and excluded. The result is an evidence base a reviewer can trust and reproduce, not a convenient selection of supportive papers.

Define the protocol

Eligibility criteria are predefined and, where appropriate, the protocol is registered prospectively, so the method is set before the results can influence it.

Predefined criteriaProspective registration

Run and document the search

A documented search strategy with a transparent record of what was found and excluded, presented in PRISMA flow diagrams and full search documentation.

PRISMA flow diagramSearch documentation

Screen and extract

Dual independent screening and structured data extraction into evidence tables, with the clinical relevance of included studies judged correctly, not just their presence in a database.

Synthesize quantitatively

When studies are comparable, we synthesise them through meta-analysis. Where head-to-head trials are missing, we apply network meta-analysis and indirect treatment comparison to estimate relative effects across a connected evidence network.

Meta-analysisNMAITC
At a Glance
Reporting standardPRISMA 2020
ScreeningDual independent
RegistrationProspective, where appropriate
SynthesisMeta-analysis, NMA, ITC
OutputsFlow diagrams and evidence tables
FeedsModels, dossiers, HTA submissions

A working method, not a theoretical service: our economic modeling has been grounded in formal literature reviews of the relevant clinical and cost evidence, so structured evidence synthesis is built into how we work.

Deliverables

What we prepare

Systematic literature reviewsTo PRISMA 2020, across clinical, economic, and humanistic questions.

Targeted and rapid reviewsWhere a full SLR is not required.

Meta-analysisQuantitative synthesis of comparable studies.

NMA and ITCNetwork meta-analysis and indirect treatment comparison.

Full documentationPRISMA flow diagrams, evidence tables, and search records.

ProtocolsProtocol development and prospective registration.

Partnership

How EvySaif helps

Our reviews are methodologically disciplined and clinician-led, so the clinical relevance of included studies is judged correctly. We document the search and selection so the review is reproducible, follow PRISMA 2020 throughout, and connect the synthesis directly to the economic model or dossier it supports.

Predefine the protocol and register it where appropriate
Document the search so the review is reproducible
Screen dually and extract into evidence tables
Synthesize through meta-analysis or NMA

Why EvySaif

EvySaif ranks among the best research and medical writing consultancies in India. Our reviews are methodologically disciplined and clinician-led, so the clinical relevance of included studies is judged correctly, not just their presence in a database. We document the search and selection so the review is reproducible, and connect the synthesis directly to the economic model or dossier it supports.

Questions

Frequently asked questions

A systematic review uses a predefined, documented method (search, eligibility, dual screening) so it is reproducible and minimises bias. A narrative review is selective and not reproducible. HTA bodies expect the systematic approach.

Yes. When direct head-to-head trials are unavailable, we use network meta-analysis and indirect treatment comparison to estimate relative effects across a connected evidence network.

PRISMA 2020, with prospective protocol registration where appropriate.

Have a different question?

Tell us about your product, market, and timeline, and a clinician on our team will reply with specifics rather than a sales script.

Request a proposal
Last updated: July 2026. Regulatory forms, portals, and timelines change; specifics are re-verified periodically.

Need a rigorous evidence base?

Tell us your question and evidence needs, and we will come back with a scoped SLR or meta-analysis quote.

Request a proposal